Chemical formula: C₁₅H₁₈N₈O₅ Molecular mass: 390.354 g/mol PubChem compound: 219024
Regadenoson is indicated for:
Population group: only adults (18 - 65 years old)
Regadenoson is a selective coronary vasodilator for use in adults as a pharmacological stress agent for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 years old or older)
Regadenoson is a selective coronary vasodilator for use in adults as a pharmacological stress agent for the measurement of fractional flow reserve (FFR) of a single coronary artery stenosis during invasive coronary angiography, when repeated FFR measurements are not anticipated.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Regadenoson is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.